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Abstract
During the course of infection, pathogens often induce changes in gene expression in host cells and
these changes can be long lasting and global or transient and of limited amplitude. Defining how,
when, and why bacterial pathogens reprogram host cells represents an exciting challenge that opens
up the opportunity to grasp the essence of pathogenesis and its molecular details.
Introduction and context
It has been known for decades that various viruses,
bacteria, and parasites can manipulate the host cell
transcriptome to downregulate the host cell inflamma-
tory response or to promote cell proliferation. With the
development of microarray technology and transcrip-
tomic analysis, a plethora of gene expression profiling
studies in various pathogen models led to the character-
ization of Toll-like receptor (TLR)-common and -specific
responses to microbial molecular patterns in the early
2000s and of a ‘core host response’ independent of the
cell and pathogen types corresponding to a ‘global alarm’
to infection [1]. These studies also pointed to the fact that
some pathogens affect the host cell genetic program. The
large majority of studies report examples of pathogens
that downregulate innate immunity. However, many
pathogens and virulence factors also affect the cell cycle
or induce cell growth.
How do pathogens alter the host genetic program? The
various strategies that have been described so far
encompass virtually every possible means of classical
gene expression manipulation. Bacteria can alter host
gene expression by integration of exogenous bacterial
DNA in the host genome, as observed in the case of the
soil bacterium Agrobacterium tumefaciens, which induces
neoplastic growth in plants [2]. Obviously, such
irreversible manipulation leading to permanent changes
in the host cell physiology suggests an intricate
coevolution between the pathogen and the host that is
expressed in the context of a slow-progressing pathology
at the frontier with symbiosis. Alternatively, plant
pathogens have been reported to activate an antibacterial
program in plant cells by inducing the synthesis of
microRNA, which interferes with auxin signaling [3].
Bacterialvirulencefactorscanactwithinthecytosolofhost
cells by altering signaling pathways regulating the
transcription of proinflammatory genes. Among the
most studied, the Yersinia YopJ/YopP, a bacterial factor
delivered into host cells by a type III secretion system
belonging to the YopJ/YopP/AvrBsT family, has been
associated with multiple functions. YopJ/P is a deubiqui-
tinating enzyme that inhibits the activation of nuclear
factor-kappa-B (NF-kB) and was also shown to have an
acetyltransferase activity that prevents the phosphoryla-
tion and activation of mitogen-activated protein kinase
(MAPK)(Figure1,#1)[4-6].BacterialtypeIIIeffectorsthat
translocate into the host cell nucleus may also alter
transcription in various ways. The plant pathogen
Xanthomonas AvrBs3 family proteins are effectors that
mimic a host transcriptional activator, which upregu-
lates Upa20, a master cell regulator controlling cell
size (Figure 1, #2) [7]. The Chlamydia trachomatis CPAF
(Clamydia protease activity factor) protein is secreted into
the cytoplasm of host cells and is responsible for the
degradation of transcription factors required for major
histocompatibility complex (MHC)-protein expression or
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response to hypoxia [8,9]. CPAF is also responsible for
massive morphological changes and nonapoptotic
death of host cells [10]. XopD, another Xanthomonas type
III effector, is a SUMO (small ubiquitin-like modifier)
protease that was reported to bind DNA and to repress
defense- and senescence-related plant genes in a process
involvingitsEAR(ERF-associated amphiphilicrepression)
motifs suggestive of its association with transcription
factors (Figure 1, #3) [7,11]. The Shigella type III effector
IpaH9.8 was also reported to regulate the activity of the
U2AF mRNA splicing factor to downregulate proinflam-
matoryprocesses(Figure1,#4)[12].Hypermethylationof
promoters during Helicobacter pylori infection of gastric
epithelial cells has also been involved in the inhibition of
transcription and immunosuppression [13].
Figure 1. How bacterial effectors manipulate host cell genetic programs
The Yersinia YopJ type III effector can affect gene expression leading to proinflammatory signals by interfering with mitogen-activated protein kinases (MAPKs)
and nuclear factor-kappa-B (NF-kB) signaling pathways. Type III effectors that translocate in the cell nucleus can also affect the transcription of
proinflammatory genes in various ways. The Xanthomonas AvrBs3 family proteins mimic a host transcriptional activator controlling cell size. Various bacterial
effectors regulate the cell cycling or cell proliferation. The bacteria effectors are depicted as solid red circles with numbers referenced in the text: 1, Yersinia
YopJ; 2, Xanthomonas AvrBs3; 3, Xanthomonas XopD; 4, Shigella IpaH9.8; 5, Shigella OspF; 6, Listeria monocytogenes lysteriolysin O, Clostridium perfringens
perfringolysin, and Streptococcus pneumoniae pneumolysin; 7, Escherichia coli cytotoxic necrotizing factors; 8, Pasteurella multocida toxin; 9, Helicobacter pylori
CagA; 10, Clostridium botulinum C3 exoenzyme and E. coli cycle inhibiting factors; 11, cytolethal distending toxins. H, nucleosome; I-kB, inhibitor of kappa-B.
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Recently, with the growing awareness of the importance
of epigenetic regulation, there has been considerable
interest in the regulation of host gene expression through
chromatin remodeling by bacterial virulence factors [14].
The Shigella type III effector OspF was shown to prevent
histone H3 phosphorylation at serine 10 [15]. This
property, associated with the OspF ability to inhibit
MAPK activation by virtue of its phosphothreonine lyase
activity, would prevent the access of the NF-kB transcrip-
tional activator to specific promoters, such as the
interleukin-8 promoter, involved in the mounting of
the inflammatory response (Figure 1, #5) [16]. The
suppression of the interferon response by Mycobacterium
tuberculosis was also correlated with chromatin remodel-
ing in a process that involves histone deacetylase activity
[17]. Bacterial soluble toxins were also shown to modify
chromatin, indicating that pathogens can alter gene
expression in a paracrine manner in cells that are not
directly infected by bacteria. The pore-forming toxins
such as the Listeria monocytogenes listeriolysin O, the
Clostridium perfringens perfringolysin, and the Streptococ-
cus pneumoniae pneumolysin induce the dephosphoryla-
tion of histone H3 combined with the deacetylation of
histone H4, which correlate with reduced transcription
of immunity genes (Figure 1, #6) [18].
Various pathogenic bacteria such as H. pylori or Bartonella
bacilliformis promote cell proliferation. Bacterial toxins
can also induce DNA replication and cell proliferation
(reviewed in [19]). In addition to their effects on the host
cell cytoskeleton, the Escherichia coli cytotoxic necrotizing
factor and Bordetella dermonecrotic toxin are deamidases
that activate Rho family GTPases, leading to Rho-
dependent mitogenic signals and to the formation of
multinucleated giant cells (Figure 1, #7). The Pasteurella
multocida toxin induces cell proliferation in a process that
depends on the heterotrimeric protein Gq/11, but
independently of its effects on RhoA (Figure 1, #8).
The stimulatory role of cell proliferation by these toxins
during bacterial infection is unclear. In contrast, there is
a possible link with cell proliferation induced by
the H. pylori CagA type IV effector protein that acti-
vates Ras signaling, possibly by directly binding to the
growth factor receptor-bound protein 2 (Grb2) adaptor
(Figure 1, #9) [20,21]. CagA, however, has been
implicated in multiple functions and could also alter
epithelial cell polarity to favor bacterial replication in the
gastric mucosa [22].
Bacterial toxins can also induce cell cycle arrest. This
particular function could represent a strategy to
prevent maturation and exfoliation of epithelial cells
to favor bacterial colonization or to alter the integrity
of the epithelial barrier. The Clostridium botulinum C3
exoenzyme, an acetyltransferase that inhibits the small
GTPase RhoA, induces cell cycle arrest in the G1 phase
(Figure 1, #10). The cytolethal distending toxins (CDTs)
first reported in E. coli, for which orthologs have been
reported in various Gram-negative bacteria (including
Shigella dysenteriae, Campylobacter spp., and Salmonella
typhi), are tripartite (CdtA, B, and C) holotoxins, with
CdtB being the active component responsible for cell
blockade [23]. Although CdtB is an endonuclease, it is
unclear whether this activity is directly responsible for
DNA damage. CdtB induces the recruitment and activa-
tion of Mre11, a nuclease of the central sensor of DNA
double-strand breaks, DNA damage, and chromatin
injury leading to cell cycle arrest [24] (Figure 1, #11).
Of note, CdtB also harbors a phosphatidyl 3,4,5 inositol
phosphatase activity that may also play a role in cell cycle
arrest by a mechanism that remains to be clarified [24].
The Cif (cycle inhibiting factor) family of proteins are
type III effectors originally reported in enteropathogenic
E. coli/enterohemorragic E. coli strains but also found in
Yersinia pseudotuberculosis and Burkholderia pseudomallei,
which induce cell cycle arrest in a process involving the
stabilization of the cyclin-dependent kinase inhibitors
p21
waf1/cip1 and p27
kip [25,26]. In addition to its role in
the delivery of type III effectors into host cells, the Shigella
protein was shown to bind to Mad2L2, an inhibitor of
the anaphase-promoting complex, and thereby to pro-
mote cell cycle arrest [27].
Future directions
How? Many bacterial effectors are proteases/actetyltrans-
ferases/deubiquitinases, some of them are endowed with
multiple activities, and many of them lack identified
targets. The question remains as to what the precise
nature and spectrum of these targets are. Addressing
these issues could allow us to clarify the links between
signaling pathways such as those regulating proteasomal
degradation, inflammation, cell proliferation, or cell
death.
When? Efforts should also aim at addressing the function
of effectors in cell types that play a role during infection.
For example, it is conceivable that toxins that induce cell
cycle arrest in epithelial cells also act as immunosup-
pressive agents by preventing the clonal expansion of
lymphocytes, as reported for the fusobacterial immuno-
suppressive protein A (FipA) [28]. The development of
new technologies to visualize, in real time, virulence
factor delivery into host cells should provide us with
clues for understanding how various effectors ‘orches-
trate’ the inflammatory response.
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are, however, examples in which a specific cluster of
inflammatory genes is targeted by a given pathogen or by
pathogens that specifically alter the host response in a
given cell type. Such examples are likely to reflect specific
features of the pathogen’s physiopathological strategy.
Also, in some instances, there are seemingly paradoxical
findings for the action of bacterial effectors. For example,
a hallmark of bacillary dysentery induced by Shigella is
acute inflammation. It has been thought that bacteria
need to elicit an inflammatory program to colonize the
colonic mucosa. As presented above, this view is now
being challenged by the discovery that many Shigella type
III effectors appear to downregulate inflammation. This
suggests that we are lacking a model that recapitulates
critical steps of the infectious process and that efforts
need to be made to develop relevant readouts. Recent
years have seen the success of what one could call
‘molecular mechanistics’ of virulence determinants.
Along with the molecular dissection of the mode of
action of bacterial virulence determinants, getting the
right messages from studying genetic reprogramming of
host cells by pathogens will obviously imply efforts to
integrate the function of these effectors in the infectious
context.
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